The DOI matches its Crossref record.
Sirolimus May Reduce Fertility in Male Renal Transplant Recipients
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Another side effect of doses of rapamycin that extend lifespan in mice is testicular degeneration, and reduced male fertility has been observed in humans treated with rapalogs.
“Another side effect of doses of rapamycin that extend lifespan in mice is testicular degeneration 25,144, and reduced male fertility has been observed in humans treated with rapalogs 145,146.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 26
- Haberman, 1991, Male fertility in cyclosporine-treated renal transplant patients, J Urol, 145, 294, 10.1016/S0022-5347(17)38318-0 · DOI
- Handelsman, 1984, Testicular function after renal transplantation: Comparison of Cyclosporin A with azathioprine and prednisone combination regimes, Clin Nephrol, 22, 144
- Holdsworth, 1977, The pituitary-testicular axis in men with chronic renal failure, N Engl J Med, 296, 1245, 10.1056/NEJM197706022962201 · DOI
- Holdsworth, 1978, A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function, Clin Nephrol, 10, 146
- Lim, 1975, Gonadal dysfunction in uremic men. A study of the hypothalamo-pituitary-testicular axis before and after renal transplantation, Am J Med, 58, 655, 10.1016/0002-9343(75)90501-X · DOI
- Palmer, 1999, Sexual dysfunction in uremia, J Am Soc Nephrol, 10, 1381, 10.1681/ASN.V1061381 · DOI
- Prem, 1996, Male reproductive function in uraemia: Efficacy of haemodialysis and renal transplantation, Br J Urol, 78, 635, 10.1046/j.1464-410X.1996.14624.x · DOI
- Eid, 1996, Assessment of sperm motion characteristics in infertile renal transplant recipients using computerized analysis, Int J Androl, 19, 338, 10.1111/j.1365-2605.1996.tb00524.x · DOI
- Armenti, 2006, Report from the National Transplantation Pregnancy Registry: Outcomes of Pregnancy After Transplantation Terasaki Foundation Laboratory (ed.), 57
- McKay, 2005, Reproduction and transplantation: Report on the AST Consensus Conference on Reproductive Issues and Transplantation, Am J Transplant, 5, 1592, 10.1111/j.1600-6143.2005.00969.x · DOI
- Bererhi, 2003, Rapamycin-induced oligospermia, Transplantation, 76, 885, 10.1097/01.TP.0000079830.03841.9E · DOI
- Boobes, 2007, High incidence of infertility in men and women kidney transplant patients receiving sirolimus, J Am Soc Nephrol, 18, 236A
- Deutsch, 2007, Sirolimus-associated infertility: Case report and literature review of possible mechanisms, Am J Transplant, 7, 2414, 10.1111/j.1600-6143.2007.01929.x · DOI
- Fritsche, 2004, Testosterone concentrations and sirolimus in male renal transplant patients, Am J Transplant, 4, 130, 10.1046/j.1600-6135.2003.00279.x · DOI
- Huyghe, 2007, Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: An overview, Transpl Int, 20, 305, 10.1111/j.1432-2277.2006.00423.x · DOI · Paper page
- Kaczmarek, 2004, Sirolimus impairs gonadal function in heart transplant recipients, Am J Transplant, 4, 1084, 10.1111/j.1600-6143.2004.00456.x · DOI
- Skrzypek, 2007, Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment, Andrologia, 39, 198, 10.1111/j.1439-0272.2007.00787.x · DOI
- Tondolo, 2005, Sirolimus impairs improvement of the gonadal function after renal transplantation, Am J Transplant, 5, 197, 10.1111/j.1600-6143.2005.00604.x · DOI
- Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
- Feng, 2000, Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia, J Biol Chem, 270, 25572, 10.1074/jbc.M002218200 · DOI
- De Celis, 1999, Male fertility of kidney transplant patients with one to ten years of evolution using a conventional immunosuppressive regimen, Arch Androl, 42, 9, 10.1080/014850199262995 · DOI
- Rapamune ® FDA Pharmacology Review, approved 09 July 2004. US Food and Drug Administration, Center for Drug Evaluation and Research. NDA 21–083.
- Seethalakshmi, 1990, Cyclosporine: Its effects on testicular function and fertility in the prepubertal rat, J Androl, 11, 17, 10.1002/j.1939-4640.1990.tb01568.x · DOI
- McKay, 2006, Pregnancy in recipients of solid organs–effects on mother and child, N Engl J Med, 354, 1281, 10.1056/NEJMra050431 · DOI
- Kramer, 2005, Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab, Transplant Proc, 37, 1601, 10.1016/j.transproceed.2004.09.026 · DOI
- Kissel, 2000, Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses, Embo J, 19, 1312, 10.1093/emboj/19.6.1312 · DOI
Cited by
Sorted by citations
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Lamming, D. W., Ye, L., Sabatini, D. M., & Baur, J. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64099 · Cited by 531
Targeting the biology of aging with mTOR inhibitors
Mannick, J. B., & Lamming, D. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00416-y · Cited by 372
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Adverse events associated with mTOR inhibitors
Pallet, N., & Legendre, C. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.752814 · Cited by 198
Self-citation
Metadata
- Authors
- Zuber, J., Anglicheau, D., Elie, C., Bererhi, L., Timsit, M.-O., Mamzer-Bruneel, M.-F., Ciroldi, M., Martinez, F., Snanoudj, R., Hiesse, C., Kreis, H., Eustache, F., Laborde, K., Thervet, E., & Legendre, C.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 8
- Issue
- 7
- Pages
- 1471-1479
- ISSN
- 1600-6135
- Cited by
- 148
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review